Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Bayer ( (DE:BAYN) ) just unveiled an announcement.
Bayer AG announced a managerial transaction involving Ertharin Cousin, a member of its administrative body, who purchased shares as part of a commitment by the Board of Management to buy Bayer AG shares. This transaction, valued at approximately $45,518.52, reflects the company’s ongoing efforts to align management interests with shareholder value, potentially impacting investor confidence and market perception.
More about Bayer
Bayer Aktiengesellschaft is a global enterprise with core competencies in the life sciences fields of health care and agriculture. The company is known for its pharmaceuticals, consumer health products, and crop science solutions, focusing on innovation and sustainability to address global challenges.
YTD Price Performance: 22.60%
Average Trading Volume: 757,828
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €23.14B
See more insights into BAYN stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue